MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

MS meditation, whether through mindfulness, breathwork, or guided walking, can help you manage the stress of living with the disease.

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

LONDON — A 4-week period of inpatient multidisciplinary rehabilitation was associated with improvements in quality of life in patients with multiple sclerosis (MS) in a new Danish study. And a ...

East Hanover, NJ – May 22, 2024 – A team of experts in multiple sclerosis (MS) research recommends a structured approach to the study of mechanisms of exercise training for improving outcomes for ...

SAN DIEGO -- Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple sclerosis (SPMS), the phase III HERCULES trial showed. The Bruton's ...

Some treatments for multiple sclerosis (MS) help ease day-to-day symptoms, while others can help control an attack (relapse). Other medicines are designed to limit further damage to the nervous system ...

Higher consumption of oily fish such as tuna and salmon or lean fish like cod and perch is associated with a reduced risk for disability progression in patients with multiple sclerosis (MS), a new ...

Feb. 25 (UPI) --A diet rich in fish may help slow down the progression of the incurable, often disabling autoimmune disease of multiple sclerosis, according to new, long-term Swedish study published ...

Please provide your email address to receive an email when new articles are posted on . High intake of oily and lean fish reduced the risk for confirmed worsening disability in adults with MS. The ...